Geron Corporation: IMPACT-MF Study Discontinuation May Not Be So Disastrous
With the MF label expansion closed, Geron Corporation will focus on maximizing Rytelo's approved lower-risk MDS indication. I rate the GERN stock as Hold. Click to know more.